News

Hong Kong has issued a patent to Intec Pharma for its investigational Accordion Pill Carbidopa/Levodopa (AP-CD/LD) drug delivery for Parkinson’s disease symptoms in advanced patients. The patent (HK1158545) is titled “Carbidopa/Levodopa Gastroretentive Drug Delivery” and is scheduled to remain active until April 2029. The patent belongs to Intec’s IN-7 patent family that…

When a resupply mission lifts off in August bound for the International Space Station, it will be carrying an important cargo for researchers studying Parkinson’s disease: a protein considered  to be a key to potential future therapies. The leucine-rich repeat kinase 2 (LRRK2) protein will be the focus of an experiment conducted…

A new study has found that Parkinson’s disease is associated with changes in the visual system, a feature that can be detected earlier than the most common symptoms of the disease, suggesting it could be used as a biomarker to follow disease progression. The study “Visual System Involvement in Patients with…